Trial Profile
Pharmacokinetics (PK) of indacaterol acetate and mometasone furoate delivered alone or in combination following once daily inhalation via Breezhaler in healthy subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2015
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary) ; Indacaterol/mometasone (Primary) ; Mometasone (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- 25 Mar 2015 New trial record